文献速递瓣膜外科

老年患者机器人二尖瓣修复术优于标准胸骨切开术

Benefits of Robotic Mitral Valve Repair in Older Adult Patients: An Adjusted Comparison With Standard Sternotomy.
PubMed 文献 · Ann Thorac Surg · 2025-04-25

本研究比较65岁以上患者机器人二尖瓣修复与正中胸骨切开术的效果。倾向性评分匹配后每组189例,机器人组输血更少、术后房颤发生率更低、ICU和住院时间更短,长期生存和再干预率无显著差异。

要点

  • 机器人二尖瓣修复在老年患者中短期结果优于胸骨切开术
  • 机器人组输血率21% vs 32%,术后房颤33% vs 44%
  • 两组长期生存和再干预率无显著差异

核心结论

  • 老年患者机器人二尖瓣修复短期术后结果优于标准胸骨切开术,长期结果相似。

研究设计与样本

  • 研究纳入613例65岁及以上首次孤立二尖瓣修复患者,采用倾向性评分匹配比较机器人入路与正中胸骨切开术。
  • 匹配后每组各189例,中位年龄70岁(范围67-74岁),女性占33.1%,术前均为重度二尖瓣反流。

主要发现

  • 总体手术死亡率为0.3%。
  • 机器人组输血需求少于胸骨切开组(21% vs 32%)。
  • 机器人组术后心房颤动发生率低于胸骨切开组(33% vs 44%)。
  • 机器人组ICU停留时间缩短3小时,总住院时间缩短1天。
  • 匹配组间长期生存无显著差异(P = .65),二尖瓣再干预率无显著差异(P = .77),生活质量改善程度相似。

临床怎么用

  • 对于65岁以上重度二尖瓣反流需行孤立修复的患者,机器人入路可减少输血、术后房颤并缩短ICU和住院时间。
  • 机器人入路与胸骨切开术长期生存和再干预率相似,选择术式时可综合考虑短期恢复优势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of mitral regurgitation (MR) increases with age, but the invasiveness of surgical intervention may delay treatment in older adult patients. The present study compares the results of robotic mitral valve (MV) repair in patients aged more than 65 years with outcomes of MV repair performed by median sternotomy. METHODS: The study identified 613 patients aged 65 years or older who underwent isolated MV repair for the first time through a robotic approach or standard median sternotomy. Propensity score matching was used to adjust for baseline differences. Primary end points were long-term all-cause mortality, reintervention-free survival, probability of moderate or severe MR during follow-up, and quality of life outcomes. RESULTS: The 189 matched patients in each group had similar baseline characteristics. The median age was 70 years (range, 67-74 years), and 33.1% of the participants were female. All patients had severe MR before operation. Overall operative mortality was 0.3%. Compared with patients in the sternotomy group, those in the robotic group required fewer blood transfusions (21% vs 32%), had a lower incidence of postoperative atrial fibrillation (33% vs 44%), and had shorter intensive care unit stays (-3 hours) and total hospital stays (-1 day). There was no significant difference in long-term survival between the matched groups (P = .65). Similarly, long-term trends of progression of MR were comparable, as were rates of MV reintervention (P = .77). Patients in both groups reported a similar degree of improvement in quality of life postoperatively. CONCLUSIONS: Robotic MV repair in older patients is associated with better short-term postoperative outcomes compared with standard median sternotomy, and long-term outcomes are similar.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Sawma T, Arghami A, Rowse PG, et al. Benefits of Robotic Mitral Valve Repair in Older Adult Patients: An Adjusted Comparison With Standard Sternotomy. Ann Thorac Surg. 2025. PMID: 40288731. doi:10.1016/j.athoracsur.2025.04.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。